Medscape March 14, 2024
On a November morning in 2022, James Messenger opened wide and swallowed a capsule like no other.
Messenger was no stranger to taking pills.
He’d first experimented with prescription opioids as a teenager in Morgantown, West Virginia, battled addiction on-and-off since, and known more than 70 people who had fatally overdosed. So, when asked to test a new “smart pill” that could detect an overdose in progress and call for help, he didn’t hesitate to join the study.
“I’ve lost pretty much every good friend I’ve ever had to this,” said Messenger. “This pill could save a lot of lives.”
The new Vitals Monitoring capsule he tested is just one example in a growing effort to radically rethink what the...
Today's Sponsors
Today's Sponsor